SYLVANT® is indicated for the treatment of adult patients with multicentric Castleman’s disease (MCD) who are human immunodeficiency virus (HIV) negative and human herpesvirus-8 (HHV-8) negative. For further information (including side effects) Please read the Sylvant PI as approved by the Israeli MOH.